AII
CRL icon

AGF Investments Inc’s Charles River Laboratories CRL Stock Holding History

AGF Investments Inc’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-27
Closed -$10K – 495
2021
Q4 		$10K Hold
27
– – ﹤0.01% 690
2021
Q3 		$11K Sell
27
-4
-13% -$1.66K ﹤0.01% 690
2021
Q2 		$11K Sell
31
-11
-26% -$3.67K ﹤0.01% 699
2021
Q1 		$12K Buy
+42
New +$11.7K ﹤0.01% 712
2020
Q2 		– Sell
-9
Closed -$1K – 826
2020
Q1 		$1K Buy
+9
New +$1.35K ﹤0.01% 784

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AGF Investments Inc's CRL Position: Q1 2022 in Review

AGF Investments Inc sold out of Charles River Laboratories (CRL) in Q1 2022, closing a stake of 27 shares — an estimated $10K sold.

AGF Investments Inc first reported a position in CRL in Q1 2020 and held it in 5 quarters. The position peaked at $12K in Q1 2021. 644 funds tracked by Wall St. Rank hold CRL as of Q1 2022.

  • AGF Investments Inc reported no remaining Charles River Laboratories position as of Q1 2022 after selling out during the quarter.
  • AGF Investments Inc sold 27 Charles River Laboratories shares in Q1 2022, an estimated $10K.
  • AGF Investments Inc first reported a position in Charles River Laboratories in Q1 2020 and held it in 5 quarters.
  • AGF Investments Inc's Charles River Laboratories position peaked at $12K in Q1 2021.
  • 644 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2022.

Based on AGF Investments Inc's 13F filing for Q1 2022, filed 10 May 2022.